1284 related articles for article (PubMed ID: 16912138)
1. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
[TBL] [Abstract][Full Text] [Related]
2. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies.
Maghnie M; Ambrosini L; Cappa M; Pozzobon G; Ghizzoni L; Ubertini MG; di Iorgi N; Tinelli C; Pilia S; Chiumello G; Lorini R; Loche S
J Clin Endocrinol Metab; 2006 Aug; 91(8):2900-5. PubMed ID: 16684828
[TBL] [Abstract][Full Text] [Related]
3. Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient.
Cacciari E; Tassoni P; Parisi G; Pirazzoli P; Zucchini S; Mandini M; Cicognani A; Balsamo A
J Clin Endocrinol Metab; 1992 Jun; 74(6):1284-9. PubMed ID: 1592872
[TBL] [Abstract][Full Text] [Related]
4. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
Léger J; Danner S; Simon D; Garel C; Czernichow P
J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
[TBL] [Abstract][Full Text] [Related]
5. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
Colmenares A; González L; Gunczler P; Lanes R
J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
[TBL] [Abstract][Full Text] [Related]
6. Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient.
Cacciari E; Tassoni P; Cicognani A; Pirazzoli P; Salardi S; Balsamo A; Cassio A; Zucchini S; Colli C; Tassinari D
J Clin Endocrinol Metab; 1994 Dec; 79(6):1663-9. PubMed ID: 7989472
[TBL] [Abstract][Full Text] [Related]
7. Subnormal serum insulin-like growth factor-I levels in young adults with childhood-onset nonacquired growth hormone (GH) deficiency who recover normal gh secretion may indicate less severe but persistent pituitary failure.
Gelwane G; Garel C; Chevenne D; Armoogum P; Simon D; Czernichow P; Léger J
J Clin Endocrinol Metab; 2007 Oct; 92(10):3788-95. PubMed ID: 17666477
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment: Retesting early in the course of GH treatment.
Vuralli D; Gonc EN; Ozon ZA; Alikasifoglu A; Kandemir N
Growth Horm IGF Res; 2017 Jun; 34():31-37. PubMed ID: 28511077
[TBL] [Abstract][Full Text] [Related]
9. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
11. Growth Hormone (GH) Therapy During the Transition Period: Should We Think About Early Retesting in Patients with Idiopathic and Isolated GH Deficiency?
Penta L; Cofini M; Lucchetti L; Zenzeri L; Leonardi A; Lanciotti L; Galeazzi D; Verrotti A; Esposito S
Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30678118
[TBL] [Abstract][Full Text] [Related]
12. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment.
Tauber M; Moulin P; Pienkowski C; Jouret B; Rochiccioli P
J Clin Endocrinol Metab; 1997 Feb; 82(2):352-6. PubMed ID: 9024217
[TBL] [Abstract][Full Text] [Related]
14. Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment.
Chaler EA; Rivarola MA; Guerci B; Ciaccio M; Costanzo M; Travaglino P; Maceiras M; Pagani S; Meazza C; Bozzola E; Barberi S; Bozzola M; Belgorosky A
Horm Res; 2006; 66(5):231-5. PubMed ID: 16912509
[TBL] [Abstract][Full Text] [Related]
15. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
[TBL] [Abstract][Full Text] [Related]
16. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
Huang YH; Wai YY; Van YH; Lo FS
J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
[TBL] [Abstract][Full Text] [Related]
18. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA
J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760
[TBL] [Abstract][Full Text] [Related]
20. Analysis of bone age maturation and growth velocity in isolated growth hormone (GH) deficient boys with and without gonadal suppression treatment and in GH deficient boys with associated gonadotropin deficiency.
Satoh M; Tanaka T; Hibi I
J Pediatr Endocrinol Metab; 1997; 10(6):615-22. PubMed ID: 9467132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
